Summary: Henry Schein has expanded its executive management committee with the appointments of Steve Boggan and Bianka Wilson as co-CEOs of the Global Oral Reconstruction Group (GORG), and Tom Popeck as CEO of the Healthcare Specialties Group (HSG). GORG focuses on dental implants and biomaterials, while HSG targets high-growth dental and orthopedic markets. These strategic units are crucial for the company’s BOLD+1 initiative, aimed at offering high-margin specialty products and services to enhance its broader business portfolio.

Key Takeaways:

  • Henry Schein made three key appointments to its executive management committee to drive growth.
  • The company’s emphasis on GORG and HSG highlights its focus on sectors with potential for high growth.
  • The executives bring experience to bolster Henry Schein’s position in the healthcare market.

Henry Schein appointed three new members to its executive management committee (EMC) – Steve Boggan and Bianka Wilson, recently named co-chief executive officers of the company’s global oral reconstruction group (GORG), and Tom Popeck, CEO of the company’s healthcare specialties group (HSG).

Strategic Importance of GORG and HSG

GORG includes the company’s portfolio of implant lines and a full range of biomaterial products. HSG includes a range of company-owned manufacturing brands in the endodontic, orthodontic, and orthopedic markets.

According to the company, the GORG and HSG units are key to progressing Henry Schein’s BOLD+1 strategic initiative, specifically aimed at developing specialty products and services with higher growth and margins. These offerings aim to enhance the company’s distribution, software, and value-added businesses.

Backgrounds of the New Executive Members

Boggan joined Henry Schein in 2013 with the company’s acquisition of BioHorizons, which he led as president and CEO. As co-CEO of GORG, Boggan will lead commercial operations in North and South America and the Middle East as well as global marketing.

Wilson joined Henry Schein in 2018 previously serving as Group CFO of Ascom Holding AG. Wilson was serving as chief financial officer of GORG and, as co-CEO, she will lead strategy, finance, and human resources as well as the group’s business in Europe and APAC.

Popeck joined Henry Schein in 2019 with more than 20 years of sales leadership and general management experience, including in the medical device sector. In 2023, he was promoted to president of HSG.

Leadership’s Perspective

“We are delighted to welcome three strong and proven leaders to the Henry Schein Executive Management Committee,” said Stanley Bergman, chairman and CEO of Henry Schein, Inc. “Steve, Bianka, and Tom have each demonstrated vision and commitment in inspiring and leading our teams to excellence in a quickly changing global healthcare marketplace. Our senior leadership team will benefit greatly from the added perspectives of these seasoned professionals.”